ESHRE Guideline: management of women with premature ovarian insufficiency.
about
Impaired protein stability and nuclear localization of NOBOX variants associated with premature ovarian insufficiencyFMRP Associates with Cytoplasmic Granules at the Onset of Meiosis in the Human Oocyte.Environmental pollutants, a possible etiology for premature ovarian insufficiency: a narrative review of animal and human data.Re-implantation of cryopreserved ovarian cortex resulting in restoration of ovarian function, natural conception and successful pregnancy after haematopoietic stem cell transplantation for Wilms tumour.Increased detection of co-morbidities with evaluation at a dedicated adult Turner syndrome clinic.Current Success and Efficiency of Autologous Ovarian Transplantation: A Meta-Analysis.Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates.Knowledge and attitudes of health professionals regarding menopausal hormone therapies.A mother's gift of life: exploring the concerns and ethical aspects of fertility preservation for mother-to-daughter oocyte donation.The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?Occult form of premature ovarian insufficiency.Occult Form of Premature Ovarian Insufficiency in Women with Infertility and Oligomenorrhea as Assessed by Poor Ovarian Response Criteria.A common African variant of human connexin 37 is associated with Caucasian primary ovarian insufficiency and has a deleterious effect in vitro.The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.Premature Ovarian Insufficiency - an update on recent advances in understanding and management.Menstrual cycle characteristics of young females with occult primary ovarian insufficiency at initial diagnosis and one-year follow-up with serum amh level and antral follicle count.Effects of low-intensity pulsed ultrasound (LIPUS)-pretreated human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation on primary ovarian insufficiency in rats.Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.Estrogen treatment in infertile women with premature ovarian insufficiency in transitional phase: a retrospective analysis.Estrogen-based hormone therapy in women with primary ovarian insufficiency: a systematic review.Utility of complete blood count parameters to detect premature ovarian insufficiency in cases with oligomenorrhea/amenorrhea.Novel FOXL2 mutations cause blepharophimosis-ptosis-epicanthus inversus syndrome with premature ovarian insufficiency.MicroRNA-379-5p is associate with biochemical premature ovarian insufficiency through PARP1 and XRCC6.Standard hormone therapy is inadequate for bone density in premature ovarian insufficiency.POLR2C Mutations Are Associated With Primary Ovarian Insufficiency in Women.Consanguineous familial study revealed biallelic FIGLA mutation associated with premature ovarian insufficiency.Use of Hormone Replacement in Females with Endocrine DisordersPremature ovarian insufficiency - hormone replacement therapy and management of long-term consequencesSigns and symptoms, evaluation, and management of genitourinary tract consequences of premature ovarian insufficiencyPremature ovarian insufficiency - aetiopathology, epidemiology, and diagnostic evaluationBone health and evaluation of bone mineral density in patients with premature ovarian insufficiencyReproduction in premature ovarian insufficiency patients - from latest studies to therapeutic approachAlleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damageDeterminants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial
P2860
Q29147461-C6EDD91A-1EFB-45F4-8DDC-DECBE952FB88Q36151280-8A321605-515B-4936-87E8-A4D4B7E2D28AQ36340348-7478B441-4520-49E5-AFA4-743C5227FB1EQ37519135-E5EE0745-F208-4406-9000-EB639D13717BQ38655598-2D8F2590-B82A-41C4-B96B-0B5EB7003CF9Q38682205-ABDBA2BF-59EF-4D65-B26F-2B490723BDB9Q38845245-30DB8666-F49B-40F4-B7A2-D286ED91C369Q38853529-0779136D-CA86-451D-A2AE-EF415FCACEFBQ39000007-09D6CD43-664C-400C-BF81-BB2B929A2113Q39001136-6C301936-EFE7-4F56-A7D2-FC470616C619Q39271781-AEA2284E-9B30-4036-A79F-139B4B14EE1BQ46716306-74CE4C12-81CE-4019-9564-694D88C4B221Q46985224-B3BFE5F8-CE73-4180-9572-83748B7C9190Q47097531-31F4A437-F46C-48E9-BCB7-29620E0E1EB8Q47101603-BEC426B2-FB39-458C-B0A3-00D22AAA9E87Q47127165-CA1ABA34-D509-4B53-A4BE-B07439C6B80AQ47234054-54021856-4C82-4B03-9827-0FA13E063671Q47262915-011C5A95-72DD-422F-9738-8F71F5A7760BQ47369122-FFFFD165-8BAC-4267-BB28-D92671C159A9Q47779333-76C6D425-A405-40B3-A09A-4B3D37B7A66EQ48111424-F0014BC0-6A30-456D-95FC-E24EBB5AC19FQ48149291-2F66B19D-46F4-46EA-908A-46890ECB7888Q49787194-B36F5671-BEDA-4E43-872B-C77F8067006AQ51031762-C5E7FAB2-A4F3-43F5-8508-DBBB8E7C2A76Q52734978-1A4FC4DC-252B-4EE7-8BE6-E52A59D192FBQ55341378-A3D5EEF9-6937-4D3F-9D88-0A5CD13C7090Q56029673-70AA553C-736E-41FD-A3AF-023BF7FD5183Q57823050-5152FC76-F2A4-4AA6-80F7-B1FBE769D75FQ57823053-5A38BE4A-5063-41E3-8433-0BD9F497D7DCQ57823064-EE31A822-702B-4A54-9F77-1F5B77545C36Q57823069-7C105717-43F1-44F7-A659-9596B74EFDB2Q57823071-79D74B37-A5FE-49E8-BAD1-D558227E9B9CQ58768664-8771626D-AC70-4499-B12B-E9A9F696632FQ58793373-ABBE1E4A-E569-415D-8B0A-45E04AB710E1
P2860
ESHRE Guideline: management of women with premature ovarian insufficiency.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
ESHRE Guideline: management of women with premature ovarian insufficiency.
@en
type
label
ESHRE Guideline: management of women with premature ovarian insufficiency.
@en
prefLabel
ESHRE Guideline: management of women with premature ovarian insufficiency.
@en
P2093
P2860
P356
P1433
P1476
ESHRE Guideline: management of women with premature ovarian insufficiency.
@en
P2093
B Cartwright
C Zillikens
European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI
J Bartlett
N Vermeulen
P2860
P304
P356
10.1093/HUMREP/DEW027
P407
P577
2016-03-22T00:00:00Z